NCT02584569View on ClinicalTrials.gov

Phase 1 TAK-915 Single-Dose Positron Emission Tomography (PET) Occupancy Study

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Healthy Volunteers

Interventions

DRUG

TAK-915

TAK-915 oral suspension

Trial Locations (1)

Unknown

New Haven

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY